Detection of mutated KRAS, TP53, CDKN2A, and SMAD4 in tumor cell-free DNA of Brazilian pancreatic adenocarcinoma patients using next-generation sequencing

Abstract Pancreatic adenocarcinoma (PDAC) is one of the most lethal cancer types worldwide, with early diagnosis being challenging due to nonspecific symptoms that are often noticed only when the tumor reaches a large size. Liquid biopsy has emerged as a promising technology in oncology, where the i...

書目詳細資料
發表在:	Scientific Reports
Main Authors:	Anelis Maria Marin, Branca Engel Timoner, Diogo Dias Araújo, Miyuki Uno, Maria José Ferreira Alves, Roger Chammas, Guilherme Naccache Namur, Denise Kusma Wosniaki, Federico Canzian, Lucas Blanes, Dalila Lucíola Zanette, Mateus Nóbrega Aoki
格式:	Article
語言:	英语
出版:	Nature Portfolio 2026-03-01
主題:	PDAC Pancreatic cancer Liquid biopsy CfDNA NGS
在線閱讀:	https://doi.org/10.1038/s41598-026-42403-4

相似書籍

Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer
由: Dimitrios Stefanoudakis, et al.
出版: (2024-03-01)

Circulating Cell-Free Nucleic Acids as Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer
由: Anelis Maria Marin, et al.
出版: (2023-04-01)

RBPJ Deficiency Sensitizes Pancreatic Acinar Cells to KRAS-Mediated Pancreatic Intraepithelial Neoplasia InitiationSummary
由: Leiling Pan, et al.
出版: (2023-01-01)

TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma
由: Yiran Zhou, et al.
出版: (2023-12-01)

Urinary mRNA-based biomarkers for non-muscle-invasive bladder cancer: a mini-review
由: Karoline Brito Caetano Andrade Coelho, et al.
出版: (2024-08-01)

Novel Insights into T-Cell Exhaustion and Cancer Biomarkers in PDAC Using ScRNA-Seq
由: Muhammad Usman Saleem, et al.
出版: (2025-08-01)

Evaluation of KRAS inhibitor-directed therapies for pancreatic cancer treatment
由: Szu-Aun Long, et al.
出版: (2024-05-01)

Plasma Exosome-Derived microRNAs as Potential Diagnostic and Prognostic Biomarkers in Brazilian Pancreatic Cancer Patients
由: Anelis Maria Marin, et al.
出版: (2022-05-01)

Synergistic anticancer effects of camptothecin and sotorasib in KRAS-mutated pancreatic ductal adenocarcinoma
由: Prasanna Srinivasan Ramalingam, et al.
出版: (2025-07-01)

KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma
由: Mahmoud Yousef, et al.
出版: (2025-04-01)

The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer
由: Rodrigo Entrialgo-Cadierno, et al.
出版: (2023-05-01)

KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression
由: Zining Zhang, et al.
出版: (2023-04-01)

The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta‐analysis
由: Wenli Xie, et al.
出版: (2019-03-01)

KRAS and NRF2 drive metabolic reprogramming in pancreatic cancer cells: the influence of oxidative and nitrosative stress
由: Valentina Rapozzi, et al.
出版: (2025-06-01)

KRAS inhibition reverses chemotherapy resistance promoted by therapy-induced senescence-like in pancreatic ductal adenocarcinoma
由: Analia Meilerman Abuelafia, et al.
出版: (2025-07-01)

Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53
由: Stephen L. Abrams, et al.
出版: (2022-02-01)

Correction: KRAS and NRF2 drive metabolic reprogramming in pancreatic cancer cells: the influence of oxidative and nitrosative stress
由: Valentina Rapozzi, et al.
出版: (2025-08-01)

Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression
由: James A. McCubrey, et al.
出版: (2022-07-01)

Development and evaluation of a lyophilization protocol for colorimetric RT-LAMP diagnostic assay for COVID-19
由: Nayra Oliveira Prado, et al.
出版: (2024-05-01)

Elevated KRAS protein level is associated with better survival in pancreatic cancer
由: S. M. Stålberg, et al.
出版: (2025-07-01)

CDKN2A copy number alteration in bladder cancer: Integrative analysis in patient-derived xenografts and cancer patients
由: Maria-Alexandra Papadimitriou, et al.
出版: (2024-06-01)

Cell-free DNA in medium is associated with the maturation ability of in vitro cultured oocytes
由: Yasuhisa MUNAKATA, et al.
出版: (2019-02-01)

Patient-derived organoids guide personalized therapy for KRAS-mutant pancreatic cancer: synergistic MEK/mTOR inhibition and predictive chemotherapy responses
由: Xiaorui Wang, et al.
出版: (2026-05-01)

Assessment of cfDNA Levels in Saliva Samples of Stressed Young Adults: Preliminary Study
由: Ekin Çelik, et al.
出版: (2025-04-01)

APR-246—The Mutant TP53 Reactivator—Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells
由: James Andrew McCubrey, et al.
出版: (2022-02-01)

Pancreatic cancer tumor organoids exhibit subtype-specific differences in metabolic profiles
由: Hassan A. Ali, et al.
出版: (2024-10-01)

Mutant SF3B1 promotes malignancy in PDAC
由: Patrik Simmler, et al.
出版: (2023-10-01)

Graft-Derived Cell-Free DNA Quantification following Liver Transplantation Using Tissue-Specific DNA Methylation and Donor-Specific Genotyping Techniques: An Orthogonal Comparison Study
由: Daniel R. A. Cox, et al.
出版: (2023-06-01)

Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC)
由: Han Yin, et al.
出版: (2024-08-01)

Expression of HOTAIR and PTGS2 as potential biomarkers in chronic myeloid leukemia patients in Brazil
由: Ana Paula Kubaski Benevides, et al.
出版: (2024-10-01)

Efficacy of CRISPR-Cas9 gene editing for targeting KRAS mutations in pancreatic cancer: a systematic review
由: Hashim Talib Hashim, et al.
出版: (2025-04-01)

Combination of farnesyl-transferase inhibition with KRAS G12D targeting breaks down therapeutic resistance in pancreatic cancer
由: Eszter Molnár, et al.
出版: (2024-12-01)

Impact of SERPINA3 on the Prognostic Role of KRAS G12R‐Mutated Pancreatic Ductal Adenocarcinoma Patients Receiving Gemcitabine‐Based Treatment: A Cross‐Sectional Study
由: Xinying He, et al.
出版: (2025-10-01)

Integrated Analysis of Cell-Free DNA and Novel Protein Biomarkers for Stratification and Therapy Monitoring in Stage IV Pancreatic Cancer: A Preliminary Study
由: Saskia Hussung, et al.
出版: (2024-12-01)

Metformin inhibits pancreatic cancer metastasis caused by SMAD4 deficiency and consequent HNF4G upregulation
由: Chengcheng Wang, et al.
出版: (2020-07-01)

Post‐operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and SMAD4 expression
由: Yohei Masugi, et al.
出版: (2023-09-01)

RETRACTED: Parallel Encryption With Digit Arithmetic Of Covertext Model Using Duplicated Covertext
由: Hari Murti, et al.
出版: (2022-12-01)

Epithelial to Mesenchymal Transition in Patients with Pancreatic Ductal Adenocarcinoma: State-of-the-Art and Therapeutic Opportunities
由: Julie Dardare, et al.
出版: (2021-07-01)

Bioinformatics and Functional Analyses Implicate Potential Roles for EOGT and <i>L</i>-fringe in Pancreatic Cancers
由: Rashu Barua, et al.
出版: (2021-02-01)

The Role of Autophagy in Pancreatic Cancer—Recent Advances
由: Maria New, et al.
出版: (2019-12-01)